INVO Fertility, Inc.
IVF
$1.96
-$0.06-2.97%
NASDAQ
12/31/2023 | |||||
---|---|---|---|---|---|
Revenue | 1.38M | ||||
Total Other Revenue | -- | ||||
Total Revenue | 1.38M | ||||
Cost of Revenue | 886.80K | ||||
Gross Profit | 495.00K | ||||
SG&A Expenses | 1.86M | ||||
Depreciation & Amortization | 141.60K | ||||
Other Operating Expenses | -- | ||||
Total Operating Expenses | 2.89M | ||||
Operating Income | -1.51M | ||||
Income Before Tax | -1.97M | ||||
Income Tax Expenses | 23.00K | ||||
Earnings from Continuing Operations | -1.99M | ||||
Earnings from Discontinued Operations | -- | ||||
Extraordinary Item & Accounting Change | -- | ||||
Minority Interest in Earnings | -- | ||||
Net Income | -1.99M | ||||
EBIT | -1.51M | ||||
EBITDA | -- | ||||
EPS Basic | -9.65 | ||||
Normalized Basic EPS | -- | ||||
EPS Diluted | -9.65 | ||||
Normalized Diluted EPS | -- | ||||
Average Basic Shares Outstanding | 206.80K | ||||
Average Diluted Shares Outstanding | 206.80K | ||||
Dividend Per Share | -- | ||||
Payout Ratio | -- |